Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Enliven Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ELVN
Nasdaq
8731
https://www.enliventherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Enliven Therapeutics Inc
MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors
- Apr 19th, 2024 7:03 pm
Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
- Apr 11th, 2024 7:44 pm
Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
- Apr 11th, 2024 11:55 am
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
- Apr 9th, 2024 8:05 pm
Owning 36% shares,institutional owners seem interested in Enliven Therapeutics, Inc. (NASDAQ:ELVN),
- Apr 9th, 2024 10:59 am
Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024
- Mar 28th, 2024 8:05 pm
Enliven Therapeutics Inc Director Rahul Ballal Sells 13,278 Shares
- Mar 23rd, 2024 5:51 am
Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates
- Mar 19th, 2024 12:30 pm
Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
- Mar 14th, 2024 8:05 pm
Enliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
- Feb 27th, 2024 9:05 pm
Enliven Therapeutics Inc CFO Benjamin Hohl Sells 11,870 Shares
- Jan 3rd, 2024 2:01 pm
Enliven Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
- Nov 9th, 2023 9:05 pm
7 A-Rated Biotech Stocks for Your August Buy List
- Aug 17th, 2023 10:40 am
Enliven Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
- Aug 10th, 2023 8:05 pm
Enliven Therapeutics to Present at Two Upcoming Investor Conferences
- May 31st, 2023 8:55 pm
Enliven Therapeutics Highlights Business Achievements and Reports First Quarter 2023 Financial Results
- May 11th, 2023 8:05 pm
Scroll